Caring Brands (NASDAQ:CABR) Releases Earnings Results

Caring Brands (NASDAQ:CABR) released its quarterly earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, Zacks reports.

Caring Brands Trading Up 17.6%

NASDAQ CABR opened at $1.07 on Wednesday. The company has a current ratio of 13.16, a quick ratio of 13.09 and a debt-to-equity ratio of 0.03. The stock has a 50-day moving average price of $1.03. The company has a market cap of $9.57 million and a PE ratio of -2.89. Caring Brands has a 52 week low of $0.71 and a 52 week high of $5.35.

Institutional Trading of Caring Brands

A hedge fund recently bought a new stake in Caring Brands stock. Jane Street Group LLC purchased a new position in Caring Brands, Inc. (NASDAQ:CABR) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 34,446 shares of the company’s stock, valued at approximately $30,000. Jane Street Group LLC owned about 0.25% of Caring Brands as of its most recent filing with the Securities & Exchange Commission.

Analysts Set New Price Targets

Separately, Weiss Ratings began coverage on Caring Brands in a research note on Monday, January 26th. They issued a “sell (e)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Caring Brands presently has an average rating of “Sell”.

Caring Brands Company Profile

We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.